Evekeo

Evekeo is a Central Nervous System (CNS) stimulant medication. Generally, this medicine is available in the formulation of Immediate-Release (IR) tablet. Primarily, Evekeo is used for the treatment of ADHD (Attention-deficit/hyperactivity disorder), especially for children of 3–12 years, adolescents, and adults. People can buy Evekeo Online, from various online drug stores or at any nearby pharmacy.

Along with ADHD, this medication is also used to treat narcolepsy and obesity for people 12 years and above. Amphetamine Sulfate (a generic drug) is also an active ingredient of Evekeo drug. This medication falls under the drug category of Stimulants, which makes it a CNS stimulant and may help in improving focus, lessening the factors that cause distractibility, impulsivity, and hyperactive behavioral causes, and decreasing the symptoms of ADHD.

Uses of Evekeo Medication:

Because of its active ingredient Amphetamine, this drug also helps in treating individuals suffering from daytime sleep disorder (narcolepsy) and obesity. Here, we’ll discuss every usage of Evekeo medication.

Attention-deficit/Hyperactivity Disorder (ADHD) 

ADHD is a chronic condition for which an individual has difficulty paying attention, hyperactivity, and impulsiveness. Evekeo drug helps in treating the symptoms of it including impulsivity, hyperactivity, and impulsivity. Being an ADHD stimulant, this medicine aids by increasing focus and attention power, managing and reducing impulsivity, and calming hyperactivity.

Narcolepsy 

Individuals with a sleep condition, narcolepsy, have extreme daytime sleepiness. It’s difficult for narcoleptics to stay awake for extended periods. People suffering from Narcolepsy may face serious issues with their everyday routine due to this particular health complication. 

It is believed that Evekeo may consist of wakefulness-promoting agents that assist individuals in staying awake for the needed time. This medication also contains various properties that promote wakefulness and alertness in patients.

Obesity

In an uncomplicated way, Obesity is defined as a human body that consists of excessive mass or too much mass (fat). It is well known that excessive body fat results in the risk of various health problems such as an increase in cholesterol levels that leads to heart-related diseases.

Evekeo drug is mostly for those individuals who have gone through various treatment options for reducing weight but don’t get results. So, people can use the Evekeo drug as a short-term treatment option for reducing body mass. The salt composition of Amphetamine may help individuals decrease their body fat.

Mode of Action of Evekeo Drug:

Amphetamine is the primary active ingredient of the Evekeo drug that is also responsible for the complete mechanism of action. The inhibition of monoamine oxidase and reuptake complements Evekeo drugs’ mechanism of action, working together to yield a substantial elevation in monoamine concentration. 

Finally, it is known that amphetamine inhibits the catalytic enzyme MAO, which is attached to the mitochondria and is responsible for breaking down all extra neurotransmitters. Amphetamine functions as a mild MAO inhibitor, therefore this method of action is frequently circumvented; yet, it cannot be ignored.

Dosage Guide and Effectiveness of Evekeo Tablets:

Dosage Strengths of Evekeo (Amphetamine Sulfate):

• Oral tablet – Evekeo 5 mg and Evekeo 10 mg.

Dosing Instructions:

The administered dose for individuals with ADHD, narcolepsy, and obesity varies. The optimal starting dose of Evekeo usually ranges from 2.5 mg to 5 mg. So, let’s acknowledge the dosage guide of the particular health complications.

• ADHD – Healthcare professionals administer a dose of 2.5 mg to children aged 3 to 6 years. For children above 6 years, the typical dose is 5 mg. Keep in mind that, the dose should be taken one or two times a day. In case of twice, maintain a gap of 4 – 6 hours between both doses.
• Narcolepsy – For individuals with narcolepsy, the usual dose ranges from 5 mg to 60 mg per day. Children aged 6 – 12 years are suggested to consume a dose of 5 mg a day. Whereas, for children above 12 years, the dose starts with 10 mg in a single day.
• Obesity – According to medical experts, obese (people with obesity) are recommended to take a dose of up to 30 mg in a single day. It is important to note that, the Evekeo drug is not intended to be used by children below 12 years for obesity purposes.

Efficacy:

Healthcare professionals suggest that Evekeo medication should be consumed after a meal. Individuals can experience the efficacy of this drug in around 30 to 60 minutes after being consumed. The medication retains its peak effects for up to 6 hours.

The effectiveness of the medication can be interrupted due to various factors such as individual age, body weight, height, present health condition as well as past medical history, response to the drug, tolerance capability, and metabolism. Bear in mind, that Evekeo is a prescription-only drug and should be taken after the guidance of a healthcare expert.

Side Effects of Evekeo Drug

Listed below are the most common side effects of Evekeo tablets:

• Stomach ache
• Headache
• Difficulty in sleeping
• Nervousness
• Loss of weight
• Vomiting
• Agitation
• Constipation
• False sense of well-being
• Unpleasant taste
• Sexual problems
• Itching
• Diarrhea
• Dry mouth
• Mood swing
• Hives
• Dark urine
• Fainting
• Shivering
• Excessive sweating
• Hoarseness

Precautions:

• Evekeo medicine is classified as a Schedule Controlled Substance Class II (CII) due to the presence of Amphetamine, which can be abused by individuals who take illicit or prescription medications.
• Avoid consuming alcohol and marijuana while using the Evekeo drug. Marijuana and alcohol can make a person dizzy.
• Individuals who are allergic to Amphetamine or components like it such as Dextroamphetamine, Lisdexamfetamine, etc., should stay away from the Evekeo and this particular drug.
• Avoid consuming grapefruits and their liquids along with others like cranberry juice, etc. These products can affect the efficacy of Evekeo medicine.
• Store Evekeo drugs in cold temperatures and away from highly heated temperatures.

Important Safety Information

Evekeo (amphetamine sulfate) carries the same FDA boxed warning that applies to every amphetamine-class stimulant, including Adderall: a high potential for abuse and misuse that can lead to a substance use disorder, including addiction, even at prescribed doses, and misuse by taking more than prescribed or by a route other than swallowing raises the risk of overdose and death.

Evekeo’s label also carries the same class-wide warnings covered in more depth on our Adderall safety information: sudden death in patients with existing structural heart problems, cardiomyopathy, serious arrhythmia, or coronary artery disease; new or worsened psychiatric symptoms, including psychosis or mania, even in people with no prior psychiatric history; and peripheral vasculopathy, including Raynaud’s phenomenon (fingers or toes turning white or blue, numb, or painful, usually triggered by cold or stress) rare cases have progressed to digital ulceration, which warrants a call to your prescriber rather than waiting.

Because Evekeo and Adderall share the same active isomers (dextroamphetamine and levoamphetamine, just in a different ratio, see below), these risks aren’t separate concerns unique to one drug or the other; they’re a property of the amphetamine class itself. If you want the fuller breakdown of what’s a formal FDA contraindication versus a labeled warning/precaution, that distinction is covered in depth on the Adderall page and applies to Evekeo without modification.

Who Should Not Take Evekeo

The FDA label lists two formal contraindications: known hypersensitivity to amphetamine or any Evekeo ingredient, and current use of , or use within the last 14 days of, a monoamine oxidase inhibitor (MAOI), including linezolid and IV methylene blue, which act as MAOIs even though they’re not typically thought of that way. Combining Evekeo with an MAOI can cause a hypertensive crisis.

Beyond those two, the same list of conditions handled as practical contraindications for Adderall applies here too, existing heart disease, moderate-to-severe hypertension, hyperthyroidism, a history of drug abuse or current agitated states, and glaucoma. Rather than repeat that discussion, see Important Safety Information on the Adderall page for the full two-tier breakdown; the underlying pharmacology and risk profile don’t change based on which amphetamine product is prescribed. Give your prescriber a complete medical and family history, including cardiac history, before starting, and never take Evekeo from someone else’s prescription.

Three FDA-Labeled Uses, One Medication

Most stimulants on this site are written around a single primary use. Evekeo is genuinely different: its current FDA label covers three separate indications, and the differences between them matter for dosing, age eligibility, and how long treatment is expected to last.

ADHD. Labeled as “an integral part of a total treatment program” that typically also includes psychological, educational, and social measures, not as a standalone fix.

Narcolepsy. Evekeo is labeled to reduce excessive daytime sleepiness in narcolepsy, at a usual dose range of 5 to 60 mg per day in divided doses. The label notes narcolepsy is uncommon in children under 12, but Evekeo may still be used when it does occur at that age.

Exogenous obesity. This is the indication that surprises most people, and it needs to be stated precisely rather than generalized: Evekeo is labeled as “a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction”, a short-term add-on to diet, not a long-term weight-management drug, and not approved for this use under age 12. It sits under the same boxed warning as the ADHD and narcolepsy uses. In current prescribing practice, this indication is rarely the reason someone is started on Evekeo. Most modern short-term-obesity prescribing has moved to non-stimulant options, but it remains an active, FDA-labeled use of this specific medication, and it’s worth knowing if you see it referenced on an insurance formulary, a prior-authorization form, or an older clinical note.

Because all three uses share the same boxed warning and the same core stimulant risks, having three labeled indications isn’t a sign Evekeo is “safer” or more versatile in a risk sense. It’s a sign the drug has been on the market, largely unchanged, since well before the current mixed-salt and prodrug stimulants existed, and its label reflects that longer history.

Formulated Without Dyes: What That Actually Covers

Evekeo’s manufacturer inactive-ingredient listing shows the 5 mg tablet contains no dyes or color additives, its inactive ingredients are limited to crospovidone, silicified microcrystalline cellulose, and stearic acid. This matters in practice for patients or parents managing a dye sensitivity, a dye-related behavioral concern, or a broader effort to minimize unnecessary additives in a child’s daily medication, and it’s a genuine point of difference from many other tableted stimulants that use dyes for strength-differentiation or branding.

The claim needs one precise qualifier, though: the 10 mg tablet is not dye-free. It contains the same base ingredients plus FD&C Blue #1, used to visually distinguish it from the 5 mg strength. So “Evekeo is dye-free” is accurate for the 5 mg tablet and inaccurate for the 10 mg tablet; if a dye sensitivity is a deciding factor in your household, that’s a specific detail to confirm with your pharmacist at the strength actually being dispensed, not something to assume holds across the whole product line.

Why Evekeo Is Approved Down to Age 3

Evekeo’s FDA label states it is “not recommended for children under 3 years of age” for ADHD meaning the labeled floor is age 3, with dosing starting at 2.5 mg once daily for ages 3–5 and stepping up to 5 mg once or twice daily at age 6 and older. That’s notably younger than Adderall XR, which is not approved under age 6, though it lines up with immediate-release Adderall and with Dexedrine tablets, both also labeled from age 3, see Dexedrine for that comparison. Older, immediate-release amphetamine products as a category tend to carry these younger labeled starting ages; it’s the newer extended-release and prodrug formulations that generally start later.

One disambiguation worth knowing if you’re evaluating Evekeo alongside its own product family: Evekeo ODT, the orally-disintegrating version, is a separate product with its own label, and it’s approved only for ADHD, only from age 6 to 17, it does not carry the narcolepsy or obesity indications, and its age-3 floor doesn’t apply. If a prescription or an insurance formulary references “Evekeo,” it’s worth confirming which product, the standard tablet described on this page, or the ODT version, since the two have different approved ages and different inactive-ingredient lists.

As with any stimulant used in a young child, growth (height and weight) should be tracked on a growth chart throughout treatment, since appetite suppression and slowed growth rate are a documented risk across the amphetamine class, not something specific to Evekeo.

The Isomer Mix: What a 1:1 Racemic Blend Actually Changes

Evekeo, Adderall, and Dexedrine all work through the same two active molecules, dextroamphetamine and levoamphetamine, just in different proportions. Rather than comparing them product by product, it’s more useful to walk through what changing that ratio actually does, since the isomer split is the real mechanism behind most of the practical differences people notice.

Evekeo is racemic amphetamine sulfate: a 1:1 mix of dextro- and levo-amphetamine (equal parts of each, by definition of “racemic”). Adderall’s four-salt formulation works out to roughly a 3:1 mix favoring dextroamphetamine (commonly cited as approximately 75:25). Dexedrine is dextroamphetamine alone, no levoamphetamine at all. See our amphetamine vs. dextroamphetamine comparison for more on that specific pairing.

What this changes for CNS/stimulant potency: dextroamphetamine is markedly more potent than levoamphetamine at driving the dopamine release responsible for the core ADHD/attention effect. A formulation with a higher dextro proportion (Adderall, and especially Dexedrine) delivers more of that specific effect per milligram than an equal-parts mix does, one reason Evekeo dosing, milligram for milligram, doesn’t map one-to-one onto Adderall or Dexedrine dosing, and doses aren’t interchangeable without a prescriber’s guidance.

What this changes for cardiovascular/peripheral effects: levoamphetamine is roughly as potent as dextroamphetamine when it comes to peripheral effects like vasoconstriction and blood pressure changes. That means Evekeo’s larger levoamphetamine share doesn’t dilute the cardiovascular side of the risk profile the way it dilutes the CNS-potency side, the cardiac, blood-pressure, and peripheral-vasculopathy warnings described above apply at essentially the same weight across all three drugs, regardless of isomer ratio.

What this changes for how the drug is dosed and taken: none of the three has an inherently longer or shorter duration purely because of isomer ratio, that’s driven mainly by formulation (immediate-release vs. extended-release vs. prodrug), not isomer mix. Evekeo is only available as an immediate-release tablet, dosed several times a day depending on indication, which is a formulation difference from Adderall XR’s once-daily dosing rather than a consequence of the 1:1 ratio itself.

The short version: a different isomer ratio changes how strong the attention/CNS effect feels relative to the dose, but it does not meaningfully change the cardiovascular or psychiatric risk profile, those apply across the amphetamine class regardless of which specific ratio a given product uses.

Missed a Dose?

Take it as soon as you remember, unless it’s late enough in the day that taking it now would interfere with sleep, in that case, skip it and resume your normal schedule the next day rather than taking it late. Never double up to make up for a missed dose; because Evekeo is dosed multiple times a day for several of its indications, doubling up is an easy mistake to make, and it increases cardiovascular and psychiatric risk without meaningfully improving symptom control for the dose already missed.

Who Needs Extra Precautions

Pregnancy, breastfeeding, and use in older adults follow the same amphetamine-class guidance covered in our Adderall Safety by Life Stage guide. Evekeo’s label states it should be used in pregnancy “only if the potential benefit justifies the potential risk to the fetus,” language consistent with the rest of the amphetamine class, so that guide’s discussion applies here without modification.

Two things specific to Evekeo worth naming directly rather than folding into that general guidance: first, if Evekeo is being considered or used for the exogenous-obesity indication rather than ADHD or narcolepsy, that use is not appropriate in pregnancy, in children under 12, or as anything other than a short-term adjunct to a calorie-restricted diet. It is not a substitute for a broader weight-management plan. Second, because Evekeo is approved from age 3, prescribers working with the youngest end of that range should be especially deliberate about growth monitoring and periodic reassessment, given how much less clinical margin there is to work with at that age compared with a 6-and-up starting point.

Storage & Disposal

Storage: Keep Evekeo in its original, labeled container, out of sight and reach of children, guests, and pets. Given its value for misuse and diversion, a locked cabinet or lockbox is worth the extra step even though this isn’t an opioid.

Disposal: Amphetamine products, including Evekeo, are not on the FDA’s flush list. If a drug take-back location or DEA take-back event isn’t available, mix unused pills with something undesirable like used coffee grounds or kitty litter, seal it in a bag or container, and place it in household trash, and scratch out any personal information on the prescription label before discarding the bottle. Never keep leftover Evekeo “just in case” once treatment ends or a dose changes.